Woodline Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Buy
79,114
+8,485
+12% +$2.35M 0.05% 399
2026
Q1
$20.9M Buy
70,629
+9,109
+15% +$2.71M 0.08% 330
2025
Q4
$16.8M Buy
61,520
+13,892
+29% +$3.77M 0.07% 346
2025
Q3
$12.9M Buy
47,628
+8,649
+22% +$2.35M 0.06% 380
2025
Q2
$10.7M Buy
38,979
+8,534
+28% +$2.32M 0.06% 416
2025
Q1
$8.08M Buy
30,445
+8,804
+41% +$2.17M 0.05% 401
2024
Q4
$5.03M Buy
+21,641
New +$4.98M 0.03% 486

Other funds holding CME

Woodline Partners's CME Position: Q2 2026 in Review

Woodline Partners increased its CME Group (CME) stake by 12% in Q2 2026, buying an estimated $2.35M and bringing the position to 79,114 shares worth $17.5M. The position accounts for 0.05% of the portfolio, ranked #399.

Woodline Partners first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.9M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Woodline Partners held 79,114 shares of CME Group worth $17.5M as of Q2 2026.
  • Woodline Partners bought 8,485 CME Group shares in Q2 2026, an estimated $2.35M.
  • CME Group made up 0.05% of Woodline Partners's portfolio in Q2 2026, its #399 holding.
  • Woodline Partners first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Woodline Partners's CME Group position peaked at $20.9M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.